{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:11:46Z","timestamp":1778710306209,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006578","name":"Chi Mei Medical Center","doi-asserted-by":"publisher","award":["108CM-TMU-10"],"award-info":[{"award-number":["108CM-TMU-10"]}],"id":[{"id":"10.13039\/501100006578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["104-2320-B-038-028"],"award-info":[{"award-number":["104-2320-B-038-028"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.yexcr.2022.113219","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T23:31:56Z","timestamp":1653521516000},"page":"113219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib"],"prefix":"10.1016","volume":"417","author":[{"given":"Chih-Wei","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai-Kuei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueh-Lun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-8169","authenticated-orcid":false,"given":"Chia-Kwung","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5553-112X","authenticated-orcid":false,"given":"Huei-Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2022.113219_bib1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/DDDT.S191303","article-title":"Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities","volume":"13","author":"Flis","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.yexcr.2022.113219_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/cells10010117","article-title":"Chronic myeloid leukemia: a model disease of the past, present and future","volume":"10","author":"Minciacchi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2022.113219_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1634\/stemcells.20-6-493","article-title":"The role of activin a in regulation of hemopoiesis","volume":"20","author":"Shav-Tal","year":"2002","journal-title":"Stem Cell."},{"key":"10.1016\/j.yexcr.2022.113219_bib4","first-page":"175","article-title":"Basic fibroblast growth factor inhibits p38-mediated cell differentiation and growth inhibition by activin A but not by histone deacetylase inhibitors in CML cells, Ann","volume":"87","author":"Chen","year":"2008","journal-title":"Hematol"},{"key":"10.1016\/j.yexcr.2022.113219_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2005.09.014","article-title":"Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1","volume":"240","author":"Morceau","year":"2006","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2022.113219_bib6","doi-asserted-by":"crossref","first-page":"C37","DOI":"10.1152\/ajpcell.00130.2013","article-title":"Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib","volume":"306","author":"Huang","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.yexcr.2022.113219_bib7","article-title":"Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2022.113219_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/eji.201646837","article-title":"CD69: from activation marker to metabolic gatekeeper","volume":"47","author":"Cibrian","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yexcr.2022.113219_bib9","doi-asserted-by":"crossref","first-page":"102453","DOI":"10.1016\/j.jaut.2020.102453","article-title":"The pivotal role of CD69 in autoimmunity","volume":"111","author":"Gorabi","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.yexcr.2022.113219_bib10","first-page":"995","article-title":"CD69 expression in B-cell chronic lymphocytic leukemia: a new prognostic marker?","volume":"86","author":"D'Arena","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2022.113219_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.molonc.2008.07.003","article-title":"The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia","volume":"2","author":"Hantschel","year":"2008","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113219_bib12","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/bcj.2011.35","article-title":"Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell\/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia","volume":"1","author":"Wisniewski","year":"2011","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.yexcr.2022.113219_bib13","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1002\/jcp.26599","article-title":"CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR-ABL-positive cells","volume":"233","author":"Huang","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2022.113219_bib14","doi-asserted-by":"crossref","first-page":"18677","DOI":"10.1038\/s41598-020-75807-x","article-title":"Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma","volume":"10","author":"Borchert","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2022.113219_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s12013-020-00930-5","article-title":"MT2A Promotes oxaliplatin resistance in colorectal cancer cells","volume":"78","author":"Zhao","year":"2020","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2022.113219_bib16","doi-asserted-by":"crossref","first-page":"105161","DOI":"10.1016\/j.tiv.2021.105161","article-title":"Time dependent impact of copper oxide nanomaterials on the expression of genes associated with oxidative stress, metal binding, inflammation and mucus secretion in single and co-culture intestinal in vitro models","volume":"74","author":"Ude","year":"2021","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yexcr.2022.113219_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.dci.2015.12.012","article-title":"Development and differentiation of the erythroid lineage in mammals","volume":"58","author":"Barminko","year":"2016","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.yexcr.2022.113219_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bbrc.2004.06.083","article-title":"Basic fibroblast growth factor antagonizes activin A-mediated growth inhibition and hemoglobin synthesis in K562 cells by activating ERK1\/2 and deactivating p38 MAP kinase","volume":"320","author":"Huang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2022.113219_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jcp.22074","article-title":"Activin A induction of erythroid differentiation through MKK6-p38\u03b1\/p38\u03b2 pathway is inhibited by follistatin","volume":"223","author":"Huang","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2022.113219_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2018.11.017","article-title":"Targeting cancer stemness in the clinic: from hype to hope","volume":"24","author":"Saygin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yexcr.2022.113219_bib21","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bbamcr.2013.03.006","article-title":"CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation","volume":"1833","author":"Ishikawa","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2022.113219_bib22","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.3892\/ijo.2013.1871","article-title":"Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-\u03baB","volume":"42","author":"Ishikawa","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2022.113219_bib23","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3324\/haematol.2018.193086","article-title":"BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia","volume":"103","author":"Srutova","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.yexcr.2022.113219_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1073\/pnas.0307075101","article-title":"Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells","volume":"101","author":"Uddin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.yexcr.2022.113219_bib25","first-page":"109","article-title":"Crosstalk between the Smad and the mitogen-activated protein kinase pathways is essential for erythroid differentiation of erythroleukemia cells induced by TGF-\u03b2, activin, hydroxyurea and butyrate","volume":"1","author":"Akel","year":"2013","journal-title":"J. Leuk. (Los Angel)."},{"key":"10.1016\/j.yexcr.2022.113219_bib26","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.3390\/ijms21103546","article-title":"The MKK-dependent phosphorylation of p38\u03b1 is augmented by arginine methylation on Arg 49\/Arg 149 during erythroid differentiation","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2022.113219_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexmp.2012.10.006","article-title":"Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients","volume":"94","author":"Werynska","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.yexcr.2022.113219_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","article-title":"The roles of metallothioneins in carcinogenesis","volume":"11","author":"Si","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2022.113219_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.febslet.2010.12.030","article-title":"Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells","volume":"585","author":"Kim","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2022.113219_bib30","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.18632\/aging.202831","article-title":"Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma","volume":"13","author":"Yao","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yexcr.2022.113219_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/cells9010157","article-title":"Metallothionein expression and its influence on the in vitro biological behavior of mucoepidermoid carcinoma","volume":"9","author":"Aquime","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2022.113219_bib32","first-page":"2609","article-title":"Macrophages in T cell\/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype","volume":"133","author":"Hartmann","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2022.113219_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jtemb.2009.02.003","article-title":"Differential quantitative zinc-induced expression of human metallothionein isogenes in haematopoietic precursor cell lines","volume":"23","author":"Maghdooni Bagheri","year":"2009","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.yexcr.2022.113219_bib34","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.7150\/ijms.57821","article-title":"Effect of MT2A on apoptosis and proliferation in HL60 cells","volume":"18","author":"Pan","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.yexcr.2022.113219_bib35","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V97.8.2406","article-title":"A model of human p210(bcr\/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR\/ABL-containing retroviral vector","volume":"97","author":"Zhao","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2022.113219_bib36","doi-asserted-by":"crossref","first-page":"e15525","DOI":"10.1371\/journal.pone.0015525","article-title":"Bcr\/Abl interferes with the Fanconi anemia\/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells","volume":"5","author":"Valeri","year":"2010","journal-title":"PLoS One"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482722002129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482722002129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:53:54Z","timestamp":1778709234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482722002129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0014482722002129"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2022.113219","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2022.113219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113219"}}